Alvotech Ordinary Shares (ALVO) Stock Price

ALVOStock

$4.95−38.51%52W

Market Cap$1.77B

P/E57.20x

PEG Ratio—

Div yield—

Beta0.22

ALVO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)8.51%

Price vs S&P 500 (4W)29.07%

VGM Score46.02

P/E Ratio (Annual)57.20x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)90.62%

Cash Flow / Share (Quarterly)$-0.78

Price vs S&P 500 (YTD)-16.33%

Gross Margin (TTM)61.53%

Net Profit Margin (TTM)-14.36%

EPS (TTM)$-0.28

10-Day Avg Trading Volume1.31M

EPS Excl Extra (TTM)$-0.28

Revenue Growth (5Y)53.35%

EPS (Annual)$0.10

Gross Margin (Annual)60.00%

Net Profit Margin (5Y Avg)-298.62%

Cash / Share (Quarterly)$0.20

P/E Basic Excl Extra (TTM)43.25x

Revenue Growth QoQ (YoY)-20.23%

P/E Normalized (Annual)57.20x

ROA (Last FY)1.88%

Revenue Growth TTM (YoY)-4.40%

EBITD / Share (TTM)$0.48

Operating Margin (TTM)18.32%

Cash Flow / Share (Annual)$-0.47

Net Income / Employee (Annual)$19,100

EV / Revenue (TTM)5.32x

Net Interest Coverage (TTM)-0.02x

ROA (TTM)-5.66%

EPS Growth QoQ (YoY)-99.06%

EV / EBITDA (TTM)20.93x

EPS Incl Extra (Annual)$0.10

Current Ratio (Annual)1.89x

Quick Ratio (Quarterly)0.76x

3-Month Avg Trading Volume0.82M

52-Week Price Return-38.51%

P/E Incl Extra (TTM)43.25x

Revenue / Employee (TTM)$385,000

P/S Ratio (Annual)2.71x

Asset Turnover (Annual)0.40x

52-Week High$9.25

Operating Margin (5Y Avg)-207.16%

EPS Excl Extra (Annual)$0.10

CapEx CAGR (5Y)51.66%

26-Week Price Return20.44%

Quick Ratio (Annual)1.07x

13-Week Price Return44.31%

Current Ratio (Quarterly)1.76x

Enterprise Value$2.99B

Revenue / Share Growth (5Y)-1.88%

Asset Turnover (TTM)0.39x

Revenue / Employee (Annual)$403,400

Inventory Turnover (Annual)1.35x

Pretax Margin (Annual)23.15%

Cash / Share (Annual)$0.55

3-Month Return Std Dev93.65%

Net Income / Employee (TTM)$-55,300

Net Interest Coverage (Annual)1.79x

EPS Basic Excl Extra (Annual)$0.10

Receivables Turnover (TTM)3.36x

EPS Incl Extra (TTM)$-0.28

Receivables Turnover (Annual)3.26x

P/S Ratio (TTM)2.84x

Pretax Margin (5Y Avg)-348.62%

Revenue / Share (Annual)$2.02

Forward P/E26.26x

Price vs S&P 500 (52W)-57.07%

P/E Ratio (TTM)43.25x

Year-to-Date Return-3.51%

5-Day Price Return-5.71%

EPS Normalized (Annual)$0.10

ROA (5Y Avg)-30.83%

Net Profit Margin (Annual)4.74%

Month-to-Date Return20.15%

EBITD / Share (Annual)$0.41

Operating Margin (Annual)17.64%

P/E Excl Extra (TTM)43.25x

EPS Basic Excl Extra (TTM)$-0.28

Inventory Turnover (TTM)1.17x

Pretax Margin (TTM)7.81%

Price vs S&P 500 (13W)42.36%

Beta0.22x

Revenue / Share (TTM)$1.80

52-Week Low$2.94

vGradeC

gGradeD

mGradeC

vgmGradeC

ALVO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 19, 2026	-$0.08	-$0.11	-30.16%(-$0.03)
Q1 2026	May 6, 2026	-$0.07	-$0.09	-28.57%(-$0.02)
Q4 2025	Mar 18, 2026	-$0.01	$0.01	+190.83%(+$0.02)
Q3 2025	Nov 13, 2025	-$0.03	-$0.11	-230.93%(-$0.08)
Q2 2025	Aug 13, 2025	-$0.00	$0.03	+1410.04%(+$0.03)

ALVO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.92

3.91

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
ALVOAlvotech Ordinary Shares	C	D	C	$4.95
AMGNAmgen Inc	C	C	B	$432.42
GILDGilead Sciences Inc	C	B	B	$145.68
ARGXargenx SE American Depositary Shares	D	A	B	$1023.21
MRNAModerna, Inc. Common Stock	D	C	A	$137.99
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$207.88
BIIBBiogen Inc. Common Stock	C	D	B	$218.50
BNTXBioNTech SE American Depositary Share	C	C	C	$102.08
NBIXNeurocrine Biosciences Inc	C	B	C	$154.06
EXELExelixis Inc	C	B	B	$54.45
HALOHalozyme Therapeutics, Inc.	C	B	B	$105.35
TECHBio-Techne Corp.	D	C	B	$72.35
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$351.46
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.97
RGENRepligen Corp	D	C	B	$176.27
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$118.15
PCVXVaxcyte, Inc. Common Stock	—	—	B	$59.84
QGENQIAGEN N.V.	C	C	B	$43.11
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$141.38
IBRXImmunityBio, Inc. Common Stock	F	A	B	$8.05
IMVTImmunovant, Inc. Common Stock	—	—	B	$41.20
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$57.80
CGONCG Oncology, Inc. Common stock	F	A	B	$74.34
CRSPCRISPR Therapeutics AG	D	B	C	$57.72
RLAYRelay Therapeutics, Inc. Common Stock	F	D	B	$18.77
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$25.19
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.00
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.01
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.76
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$29.32
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.82
KODKodiak Sciences Inc Common Stock	—	—	B	$37.72
MESOMesoblast Limited American Depositary Shares	D	B	B	$17.44
VCELVericel Corporation	D	B	B	$40.95
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$44.84
ADMAADMA Biologics, Inc.	C	C	C	$9.34
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$36.62
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$5.77
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.83
INBXInhibrx Biosciences, Inc. Common Stock	D	C	A	$123.41
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.34
NVAXNovavax Inc	B	D	C	$9.26
MAZEMaze Therapeutics, Inc. Common Stock	—	—	C	$27.44
SLBTSL Science Holding Limited Ordinary Shares	—	—	C	$2.70
REPLReplimune Group, Inc.	—	—	A	$15.50
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.45
VORVor Biopharma Inc. Common Stock	—	—	B	$22.65
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$21.70
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	B	$13.82
SANASana Biotechnology, Inc. Common Stock	—	—	B	$3.93
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	B	$24.36

About Alvotech Ordinary Shares

Alvotech is an integrated biopharmaceutical company that develops and manufactures biosimilar medicines. The company creates affordable alternatives to existing biologic therapies, expanding patient access to treatments while leveraging its integrated research, development, and manufacturing capabilities.